RedHill Biopharma Ltd. (RDHL)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 15.09M |
| Enterprise value | 10.70M |
| Trailing P/E | 0.12 |
| Forward P/E | 1.43k |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.47 |
| Price/book (mrq) | 7.29 |
| Enterprise value/revenue | 1.64 |
| Enterprise value/EBITDA | 0.41 |
Trading information
Stock price history
| Beta (5Y monthly) | 3.45 |
| 52-week change 3 | -77.21% |
| S&P500 52-week change 3 | 26.49% |
| 52-week high 3 | 3.2800 |
| 52-week low 3 | 0.2570 |
| 50-day moving average 3 | 0.4770 |
| 200-day moving average 3 | 0.7285 |
Share statistics
| Avg vol (3-month) 3 | 506.06k |
| Avg vol (10-day) 3 | 277.07k |
| Shares outstanding 5 | 31.87M |
| Implied shares outstanding 6 | 11.07M |
| Float 8 | 6.85B |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 13.73% |
| Shares short (30 Apr 2024) 4 | 753.64k |
| Short ratio (30 Apr 2024) 4 | 2.11 |
| Short % of float (30 Apr 2024) 4 | 2.65% |
| Short % of shares outstanding (30 Apr 2024) 4 | 2.36% |
| Shares short (prior month 28 Mar 2024) 4 | 906.88k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:40 |
| Last split date 3 | 23 Mar 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 366.25% |
| Operating margin (ttm) | -1,060.79% |
Management effectiveness
| Return on assets (ttm) | -15.71% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 6.53M |
| Revenue per share (ttm) | 1.01 |
| Quarterly revenue growth (yoy) | -95.60% |
| Gross profit (ttm) | N/A |
| EBITDA | -22.15M |
| Net income avi to common (ttm) | 23.92M |
| Diluted EPS (ttm) | 4.0000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 5.57M |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 1.17M |
| Total debt/equity (mrq) | 56.69% |
| Current ratio (mrq) | 0.84 |
| Book value per share (mrq) | 0.10 |
Cash flow statement
| Operating cash flow (ttm) | -35.82M |
| Levered free cash flow (ttm) | -18.23M |
© 2024 Yahoo. All rights reserved.